MedTrace Logo

Prevention of Postpartum Haemorrhage

NCT04463966 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-07-09

No results posted yet for this study

Summary

Use of Tranexamic Acid for prevention of Postpartum hemorrhage in high risk patients: Randomized Control Trial

Conditions

  • Post Partum Hemorrhage

Interventions

DRUG

Tranexamic acid injection

1 gm (100 mg/ml) slowly intravenous infusion during delivery ( administered over 10 minutes at 1 ml/minute) .

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • Shaimaa Ezzat · Police Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2021-04-30
Completion
2021-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04463966 on ClinicalTrials.gov